Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
of the major contributors to its success. VIB is committed to the growth of the dynamic life sciences cluster in Flanders. The VIB Technologies program - https://vib.be/en/technologies#/ - constitutes
-
consumption while guaranteeing optimal power production. You will work on the cutting edge of both wind energy and machine learning, two of the fastest growing scientific disciplines, to develop graph-based
-
University in European Policy Developments Position papers on European R&I policy Workshops Institutional networks Funding opportunities Horizon Europe European Partnerships INTERREG / ERDF (in Dutch: EFRO
-
development, you will also contribute to the creation of impactful presentations, working with researchers and supporting units across VIB to develop presentation materials that showcase VIB science and
-
(https://research.ugent.be/web/person/fuhui-shen-0/en ), who joined the Soete Laboratory of Ghent University in February 2025 as an Assistant Professor in the field of damage/fracture mechanics. Before, he
-
Department: Faculty of Pharmaceutical, Biomedical and Veterinary Sciences Regime Full-time Let’s shape the future – University of Antwerp The University of Antwerp is a dynamic, forward-thinking
-
in A. thaliana and wheat, which we started to functionally characterize. The Vascular Development group (https://www.derybellab.be), studies plant vascular development at the interface between
-
software are essential. Knowledge of Solidworks or similar CAD program, Matlab, Labview, PLC is a plus. For this job we expect the following qualities: • Eager to learn: urge to quickly acquire and
-
offering state-of-the-art study programmes grounded in research in a wide range of academic fields, Ghent University is a logical choice for its staff and students. YOUR ROLE AND TASKS We invite applications
-
Company description The Virology, Antiviral & Vaccine Research group at the Rega Institute, led by Prof. Johan Neyts, plays a leading role in the development of innovative antiviral strategies